The Prediction Markets

Market comparison

When will the FDA approve Intellia Therapeutics' lonvo-z?

1 venue · 3 outcome rows · 0 comparable lines · 0 verified parity · active

3 outcomes · $7K reported volume

Observed 2m ago

Recorded venue end date: Jan 1, 2028

Check settlement rules before comparing contracts. Matched outcomes may settle differently. These are stored prices; record update times do not certify live quotes. Differences exclude fees and available size.

No shared outcome identities or comparable outcome lines are available for this event. Each venue’s outcomes are listed separately.

Before 2028

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

89.0%

Bid 89.0% · Ask 92.0%

Before 2028

Open Kalshi ↗

Before July 2027

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

87.0%

Bid 86.0% · Ask 91.0%

Before July 2027

Open Kalshi ↗

Before October 2027

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

89.0%

Bid 89.0% · Ask 93.0%

Before October 2027

Open Kalshi ↗

Prices are shown as percentages of a $1 payout. “pp” means percentage points. A dash means data is unavailable.